Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Cancer Pain × resiniferatoxin × Clear all

Phase

Phase 3 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Intractable 1 Cancer Pain 1

Interventions

resiniferatoxin 1 Nerve Growth Factor 1 Ketamine 1 Antibodies 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02522611 2026-01-23

Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain

National Institutes of Health Clinical Center (CC)

Phase 1/2 Not yet recruiting

Cancer Pain, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡